Jyothi Padiadpu

Jyothi Padiadpu

Auto-generated profile, based on publicly available information

Jyothi Padiadpu

College of Pharmacy, Oregon State University, Corvallis, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ZLZhipeng Li
Zhipeng Li
MGManoj Gurung
Manoj Gurung
RRRichard R. Rodrigues
Richard R. Rodrigues
JPJyothi Padiadpu
Jyothi Padiadpu
NNNolan K. Newman
Nolan K. Newman
AMAndrey Morgun
Andrey Morgun
Microbiota contribute to the induction of type 2 diabetes by high-fat/high-sugar (HFHS) diet, but which organs/pathways are impacted by microbiota remain unknown. Using multiorgan network and transkingdom analyses, we found that microbiota-dependent impairment of OXPHOS/mitochondria in white adipose tissue (WAT) plays a primary role in regulating systemic glucose metabolism. The follow-up analysis established that Mmp12+ macrophages link microbiota-dependent inflammation and OXPHOS damage in WAT. Moreover, the molecular signature of Mmp12+ macrophages in WAT was associated with insulin resistance in obese patients. Next, we tested the functional effects of MMP12 and found that Mmp12 genetic deficiency or MMP12 inhibition improved glucose metabolism in conventional, but not in germ-free mice. MMP12 treatment induced insulin resistance in adipocytes. TLR2-ligands present in Oscillibacter valericigenes bacteria, which are expanded by HFHS, induce Mmp12 in WAT macrophages in a MYD88-ATF3–dependent manner. Thus, HFHS induces Mmp12+ macrophages and MMP12, representing a microbiota-dependent bridge between inflammation and mitochondrial damage in WAT and causing insulin resistance.

21 February 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
SGStephen J. Gaudino
Stephen J. Gaudino
ASAnkita Singh
Ankita Singh
HHHuakang Huang
Huakang Huang
JPJyothi Padiadpu
Jyothi Padiadpu
MJMakheni Jean-Pierre
Makheni Jean-Pierre
PKPawan Kumar
Pawan Kumar
IL-22 is critical for ameliorating obesity-induced metabolic disorders. However, it is unknown where IL-22 acts to mediate these outcomes. Here we examine the importance of tissue-specific IL-22RA1 signaling in mediating long-term high fat diet (HFD) driven metabolic disorders. To do so, we generated intestinal epithelium-, liver-, and white adipose tissue (WAT)-specific Il22ra1 knockout and littermate control mice. Intestinal epithelium- and liver-specific IL-22RA1 signaling upregulated systemic glucose metabolism. Intestinal IL-22RA1 signaling also mediated liver and WAT metabolism in a microbiota-dependent manner. We identified an association between Oscillibacter and elevated WAT inflammation, likely induced by Mmp12 expressing macrophages. Mechanistically, transcription of intestinal lipid metabolism genes is regulated by IL-22 and potentially IL-22-induced IL-18. Lastly, we show that Paneth cell-specific IL-22RA1 signaling, in part, mediates systemic glucose metabolism after HFD. Overall, these results elucidate a key role of intestinal epithelium-specific IL-22RA1 signaling in regulating intestinal metabolism and alleviating systemic obesity-associated disorders.

12 March 2024 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
NNNolan K. Newman
Nolan K. Newman
MMMatthew S. Macovsky
Matthew S. Macovsky
RRRichard R. Rodrigues
Richard R. Rodrigues
ABAmanda M. Bruce
Amanda M. Bruce
JPJacob W. Pederson
Jacob W. Pederson
AMAndrey Morgun
Andrey Morgun

20 October 2023 in EMBO Molecular Medicine
Verified
Journal Article
Open access
JPJyothi Padiadpu
Jyothi Padiadpu
MJManuel Garcia Jaramillo
Manuel Garcia Jaramillo
NNNolan K Newman
Nolan K Newman
JPJacob W Pederson
Jacob W Pederson
RRRichard Rodrigues
Richard Rodrigues
AMAndrey Morgun
Andrey Morgun
Clinical and preclinical studies established that supplementing diets with ω3 polyunsaturated fatty acids (PUFA) can reduce hepatic dysfunction in nonalcoholic steatohepatitis (NASH) but molecular underpinnings of this action were elusive. Herein, we used multi‐omic network analysis that unveiled critical molecular pathways involved in ω3 PUFA effects in a preclinical mouse model of western diet induced NASH. Since NASH is a precursor of liver cancer, we also performed meta‐analysis of human liver cancer transcriptomes that uncovered betacellulin as a key EGFR‐binding protein upregulated in liver cancer and downregulated by ω3 PUFAs in animals and humans with NASH. We then confirmed that betacellulin acts by promoting proliferation of quiescent hepatic stellate cells, inducing transforming growth factor–β2 and increasing collagen production. When used in combination with TLR2/4 agonists, betacellulin upregulated integrins in macrophages thereby potentiating inflammation and fibrosis. Taken together, our results suggest that suppression of betacellulin is one of the key mechanisms associated with anti‐inflammatory and anti‐fibrotic effects of ω3 PUFA on NASH.

5 October 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
JPJyothi Padiadpu
Jyothi Padiadpu
MGManuel Garcia-Jaramillo
Manuel Garcia-Jaramillo
NNNolan K. Newman
Nolan K. Newman
JPJacob W. Pederson
Jacob W. Pederson
RRRichard Rodrigues
Richard Rodrigues
AMAndrey Morgun
Andrey Morgun
Clinical and preclinical studies have established that supplementing diets with ω3 polyunsaturated fatty acids (PUFA) can reduce hepatic dysfunction in nonalcoholic steatohepatitis (NASH). Herein, we used multi-omic network analysis to unveil novel mechanistic targets of ω3 PUFA effects in a preclinical mouse model of western diet induced NASH. After identifying critical molecular processes responsible for the effects of ω3 PUFA, we next performed meta-analysis of human liver cancer transcriptomes and uncovered betacellulin as a key EGFR-binding protein that was induced in liver cancer and downregulated by ω3 PUFAs in animals with NASH. We then confirmed that betacellulin acts by promoting proliferation of quiescent hepatic stellate cells, stimulating transforming growth factor–β2 and increasing collagen production. When used in combination with TLR2/4 agonists, betacellulin upregulated integrins in macrophages thereby potentiating inflammation and fibrosis. Taken together, our results suggest that suppression of betacellulin is one of the key mechanisms associated with anti-inflammatory and antifibrotic effects of ω3 PUFA during NASH. Synopsis: Multi-omic network analysis points to mitochondrial cardiolipin precursors as candidate key lipids whereby ω3 fatty acids restore mitochondrial functioning. Multi-omic network analysis suggests betacellulin (BTC) as one of the key mediators of NASH suppressed by ω3 polyunsaturated fatty acids. Reduction of liver fibrosis by omega-3 fatty acids (especially by docosahexaenoic acid, DHA) is accomplished by simultaneous inhibition of betacellulin and TLR agonists. BTC promotes collagen production and induces TGFB2 in hepatic stellate cells. BTC together with TLR2/4 agonists stimulate expression of integrins in macrophages. DHA suppresses BTC-EGFR pathway in NASH animal model potentially preventing progression to hepatocellular carcinoma.

17 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
DDDachuan Dong
Dachuan Dong
LHLauren E. Higdon
Lauren E. Higdon
JZJiayan Zhou
Jiayan Zhou
JLJian-Xin Lin
Jian-Xin Lin
JPJyothi Padiadpu
Jyothi Padiadpu
JMJonathan S. Maltzman
Jonathan S. Maltzman
Gene expression in regulatory T cells (Tregs) is context-dependent and maintains peripheral immune homeostasis. FOXP3 is lineage defining but not sufficient for Treg function or persistence. To define the cell-intrinsic roles of the FOXP3 paralogs FOXP1 and FOXP4, we generated and studied mice with Treg-specific deletion of Foxp1 and/or Foxp4 . FOXP1 and FOXP4 are required to maintain the peripheral Treg pool through enhancing Il2ra transcription, thereby promoting sustained high-level expression of IL-2Rα and thus of the high-affinity IL-2Rαβγ complex. Integrating RNA-seq and ATAC-seq with previously published ChIA-PET and publicly available data, we propose a model of Il2ra transcriptional regulation in which in which FOXP1 and FOXP4 anchor chromatin looping of the Il2ra locus in mature Tregs, augment super-enhancer activity, and drive sustained CD25 expression. Our results reveal a unique role of FOXP1, and to a lesser extent FOXP4, in controlling Treg homeostasis. One Sentence Summary: FOXP1 and FOXP4 regulate chromatin architecture at the Il2ra locus, promoting sustained CD25 expression and maintaining the peripheral Treg pool.